Reckitt Benckiser Plc is ramping up manufacturing in the US and China to bolster its supply chain and potentially lessen its exposure to fresh trade wars. The maker of Strepsils lozenges and Durex ...

saying its $50 million operations in the country were “really small” in the context of its $85 billion global portfolio. As Shah tells it, Reckitt’s bet on Nigeria is anchored on reducing ...

And Reckitt’s exposure will still be higher than some other consumer multinationals. For example, Nestle SA produces 95% of its US sales in the country, its CEO Laurent Freixe told reporters in ...

He said Reckitt’s response to the galloping inflation in the country has been to resize inventory to smaller packs for the mass market, “sort of like a Nigeria-specific innovation”.

At the Capability Leaders Forum, marketers from AstraZeneca, Reckitt and Trainline discussed the potential of genAI to ...

The firm operates in 60 countries and sells products in more than 200, generating around 40% of sales from emerging markets. Read More on GB:RKT: Reckitt Benckiser Group NewsMORE Related Stocks ...

Reckitt’s exposure will still be higher than some other consumer multinationals. For example, Nestle SA produced 95% of its US sales in the country, its chief executive Laurent Freixe told ...

In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price ...